Affiliation:
1. Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Johns Hopkins University School of Medicine, and
2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21287
3. Department of Medicine, Division of Geriatrics, University of Mississippi Medical Center, Jackson, Mississippi 39216
4. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454
Abstract
Abstract
Context:
Physical activity (PA) is associated with 25-hydroxyvitamin D [25(OH)D] levels. Both are associated with atherosclerotic cardiovascular disease (ASCVD), but their joint association with ASCVD risk is unknown.
Objective:
To examine the relationship between PA and 25(OH)D, and assess effect modification of 25(OH)D and PA with ASCVD.
Design:
Cross-sectional and prospective study.
Setting:
Community-dwelling cohort.
Participants:
A total of 10,342 participants free of ASCVD, with moderate- to vigorous-intensity PA assessed (1987 to 1989) and categorized per American Heart Association (AHA) guidelines (recommended, intermediate, or poor).
Main Outcome Measures:
Serum 25(OH)D levels (1990 to 1992) and ASCVD events (i.e., incident myocardial infarction, fatal coronary disease, or stroke) through 2013.
Results:
Participants had mean age of 54 years, and were 57% women, 21% black, 30% 25(OH)D deficient [<20 ng/mL (<50 nmol/L)], and <40% meeting AHA-recommended PA. PA was linearly associated with 25(OH)D levels in whites. Whites meeting recommended PA were 37% less likely to have 25(OH)D deficiency [relative risk, 0.63 (95% confidence interval [CI], 0.56, 0.71)]; there was no significant association in blacks. Over 19.3 years of follow-up, 1800 incident ASCVD events occurred. Recommended PA was associated with reduced ASCVD risk [hazard ratio [HR], 0.78 (95% CI, 0.65, 0.93) and 0.76 (95% CI, 0.62, 0.93)] among participants with intermediate [20 to <30 ng/mL (50 to <75 nmol/L)] and optimal [≥30 ng/mL (≥75 nmol/L)] 25(OH)D, respectively, but not among those with deficient 25(OH)D (P for interaction = 0.04).
Conclusion:
PA is linearly associated with higher 25(OH)D levels in whites. PA and 25(OH)D may have synergistic beneficial effects on ASCVD risk.
Subject
Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference44 articles.
1. Global overview of the epidemiology of atherosclerotic cardiovascular disease;Barquera;Arch Med Res,2015
2. Heart disease and stroke statistics-2016 update: a report from the American Heart Association;Mozaffarian;Circulation,2016
3. Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease - United States, 2001-2010;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2013
4. Exercise: friend or foe?;Dangardt;Nat Rev Cardiol,2013
5. Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity;Shiroma;Circulation,2010
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献